Fried Robert N's Form 4 filing
Niagen Bioscience, Inc. (NAGE) · filed Jul 8, 2026
- Accession no.
- 0001417952-26-000002
- Filed
- Jul 8, 2026, 5:16 PM ET
- Trade date
- Jun 30, 2026
- Filing delay
- 8 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. It was filed 8 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fried Robert NCIK 0001417952 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | AGrant or awardAcquired | +1,106 | $2.71 | +$2,997.26 | 1,060,087 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.